Primary cutaneous aspergillosis in an immunocompetent patient: successful treatment with oral voriconazole.
Author(s): Craiglow B, Hinds G, Antaya R, Girardi M
Affiliation(s): Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
Publication date & source: 2009-07, Pediatr Dermatol., 26(4):493-5.
Publication type: Case Reports
We report a case of primary cutaneous aspergillosis in an immunocompetent child that responded rapidly to oral voriconazole therapy. Voriconazole may be considered as a treatment option for pediatric patients with primary cutaneous aspergillosis.
|